Treatments

Updated CHEST Guidelines on Antithrombotic Therapy in Venous Thromboembolism

By

Brandon May

Publish Date January 21, 2022

The updated CHEST guideline on antithrombotic therapy for VTE includes 4 new PICO questions as well as updated recommendations based on newer evidence.

A New Year for COVID-19 and the Pandemic: Triumphs and Challenges

By

Janice Perrone

Publish Date January 14, 2022

Dr Ryan Maves, CHEST COVID-19 Task Force Chair, talks about COVID-19-related triumphs of 2021, what clinicians can do now, and challenges for 2022.

Trends That Will Transform Asthma Care in 2022

By

Janice Perrone

Publish Date January 7, 2022

ACAAI Asthma Committee Chair Dr Jon Romeo predicts novel monoclonal antibodies and an emphasis on precision medicine could transform asthma care in 2022.

Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury

By

Steve Duffy

The designation was granted to Revive Therapeutics, a company that specializes in cannabis-based pharmaceuticals.

Chest Tube Placement vs Needle Aspiration for Spontaneous Pneumothorax

By

Bryant Moeller

Both chest tube placement and needle aspiration were considered acceptable treatments for primary spontaneous pneumothorax.

NDA for Novel Amikacin Inhalation Submitted for Rare Lung Infection

By

Steve Duffy

ALIS has previously been designated orphan drug status, breakthrough therapy status and a Qualified Infectious Disease Product.

No Benefit From Prophylactic Antimicrobials in Aspiration Pneumonitis

By

Bradley van Paridon

Use of prophylactic antimicrobial therapy was not associated with a reduction in mortality or transfer to critical care compared with patients managed with supportive care only.

Drainage Duration, Length of Hospital Stay With Different Pneumothorax Treatments

By

Anna Kitabjian

Treatment with a small pigtail catheter may shorten the drainage duration and length of hospital stay in patients with spontaneous pneumothorax.

FDA Approves New CFTR Modulator Therapy for Cystic Fibrosis

By

Britt Gambino

A new cystic fibrosis transmembrane conductance regulator modulator treatment has been approved by the FDA for use in patients aged 12 years and older.

Enteral vs Parenteral Nutrition in Critical Care Requiring Mechanical Ventilation

By

Laurel Ranger

Enteral nutritional support was not clinically superior to parenteral nutritional support in critically ill patients receiving mechanical ventilation.

Examining Compression-to-Ventilation Ratios for Optimal Neurologic, Survival Outcomes

By

Anna Kitabjian

Adults with cardiac arrest have better outcomes with continuous compressions with asynchronous ventilations or compression-to-ventilation ratios of 30:2.